Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 2.190
+0.065 (3.06%)
Jun 16, 2026, 11:19 AM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 12.04 million as of June 16, 2026. Its market cap has increased by 212.21% in one year.
Market Cap
12.04M
Enterprise Value
11.92M
Revenue
585.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.19
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 12.04M, a decrease of -64.22%. That is a compound annual growth rate of -20.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 12.04M | 31.82% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 23.60M |
| SkinBioTherapeutics | 22.03M |
| IXICO | 18.86M |
| Aptamer Group | 18.14M |
| Palatin Technologies | 17.05M |
| Fusion Antibodies | 15.00M |
| Cizzle Biotechnology Holdings | 12.54M |
| Oxford BioDynamics | 7.72M |